18.02.2022 - NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BEVERLY, Mass., Feb. 18, 2022 (GLOBE NEWSWIRE) - LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics .
BEVERLY, Mass., Oct. 29, 2021 (GLOBE NEWSWIRE) LexaGene Holdings, Inc., ( OTCQB: LXXGF; TSX-V: LXG ) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument